Canada · Delayed Price · Currency is CAD NuGen Medical Devices Statistics
Total Valuation
TSXV:NGMD has a market cap or net worth of CAD 4.54 million. The enterprise value is 20.63 million.
| Market Cap | 4.54M |
| Enterprise Value | 20.63M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:NGMD has 227.04 million shares outstanding. The number of shares has increased by 3.30% in one year.
| Current Share Class | 227.04M |
| Shares Outstanding | 227.04M |
| Shares Change (YoY) | +3.30% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 2.39% |
| Owned by Institutions (%) | n/a |
| Float | 221.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 27.40 |
| PB Ratio | -0.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 124.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.70
| Current Ratio | 0.70 |
| Quick Ratio | 0.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.10 |
| Interest Coverage | -1.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -37.48% |
| Return on Invested Capital (ROIC) | -40.54% |
| Return on Capital Employed (ROCE) | 875.80% |
| Weighted Average Cost of Capital (WACC) | 14.18% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.18 |
Taxes
In the past 12 months, TSXV:NGMD has paid 48,084 in taxes.
| Income Tax | 48,084 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is 1.56, so TSXV:NGMD's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -66.67% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 42.97 |
| Average Volume (20 Days) | 105,515 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:NGMD had revenue of CAD 165,736 and -11.02 million in losses. Loss per share was -0.05.
| Revenue | 165,736 |
| Gross Profit | 81,633 |
| Operating Income | -4.58M |
| Pretax Income | -10.97M |
| Net Income | -11.02M |
| EBITDA | -3.88M |
| EBIT | -4.58M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 1.78 million in cash and 17.87 million in debt, with a net cash position of -16.09 million or -0.07 per share.
| Cash & Cash Equivalents | 1.78M |
| Total Debt | 17.87M |
| Net Cash | -16.09M |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | -15.33M |
| Book Value Per Share | -0.07 |
| Working Capital | -1.10M |
Cash Flow
In the last 12 months, operating cash flow was -3.75 million and capital expenditures -599,562, giving a free cash flow of -4.35 million.
| Operating Cash Flow | -3.75M |
| Capital Expenditures | -599,562 |
| Depreciation & Amortization | 699,982 |
| Net Borrowing | n/a |
| Free Cash Flow | -4.35M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | 49.25% |
| Operating Margin | -2,764.59% |
| Pretax Margin | -6,617.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:NGMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.30% |
| Shareholder Yield | -3.30% |
| Earnings Yield | -242.61% |
| FCF Yield | -95.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 8, 2021. It was a reverse split with a ratio of 0.5.
| Last Split Date | Nov 8, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
TSXV:NGMD has an Altman Z-Score of -23.45 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -23.45 |
| Piotroski F-Score | 2 |